Učitavanje...
EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise
The receptor for epidermal growth factor (EGFR) is a prime target for cancer therapy across a broad variety of tumor types. As it is a tyrosine kinase, small molecule tyrosine kinase inhibitors (TKIs) targeting signal transduction, as well as monoclonal antibodies against the EGFR, have been investi...
Spremljeno u:
| Izdano u: | CNS Drugs |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer International Publishing
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5573763/ https://ncbi.nlm.nih.gov/pubmed/28791656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-017-0456-6 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|